S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

ADPT

Adaptive Biotechnologies Corp
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
24.28
−0.29 −1.18%
USD · close Sep 4
MKT CAP $3.9BP/E DIV YIELD FCF YIELD -0.62%REV TTM $308.1M +50.1%NET INCOME −$63.9MNET CASH $169.9M52W 12.41 – 26.44NEXT EARNINGS Nov 4 EST.SEC XBRL · TTM TO Invalid Date

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
−$998K
Net, 90 days
0 / 3
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Aug 26Aug 28OWEN KATEY EINTERZ · DirectorSell9,615$26.00$250K
Aug 18Aug 20HERSHBERG ROBERT · DirectorSell15,664$24.41$382K
Aug 18Aug 20HERSHBERG ROBERT · DirectorSell15,000$24.39$366K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch ADPT. Know when insiders buy.
One email the day a filing lands. Free.